Westborn et al. showed that treatment of SCID mice and Hmeso cells with the IL-1β inducing chemotherapeutic doxorubicin in combination with IL-1Ra resulted in a smaller tumor size compared to single cisplatin or IL-1Ra treatment [276]. This evidence concerns the gene IL1B and neoplasm.